Nanotechnology Now

• About Us
  
  • Advertising
  • Our Mission
  • Our Team
  • Comments
  • Friends
  • Contact
• Nanotechnology
• News
  
  • Current News
  • Press Releases
  • Submit Press
  • Press kit
  • Interviews
• Columns
• Products
  
  • Our Products
  • Books
  • Featured Books
• Directories
  
  • Companies/Academic
  • Events
  • Glossary
  • Best Of
• Career Center
• Nano-Social Network
• Nano Consulting
• My Account

Home > News > Calando Pharmaceuticals Will Jointly Develop RNAi Therapeutics

February 22nd, 2006

Calando Pharmaceuticals Will Jointly Develop RNAi Therapeutics

Abstract:
NCI To Co-Sponsor ‘Nanotechnology for Cancer Prevention, Diagnosis and Treatment’ Symposium at Nanotech 2006 Conference in Boston.

Source:
NSTI

Bookmark:

Related News Press

Nanomedicine

Dr. Ben J. Lipps designated as Chairman of the Management Board and Chief Executive Officer of Nanostart-holding MagForce AG June 17th, 2013

Iranian Scientists Produce Dynamometer for Nanoparticles, Biocells June 15th, 2013

Monell-led research identifies scent of melanoma: New research may lead to early non-invasive detection and diagnosis June 14th, 2013

Discovery of new material state counterintuitive to laws of physics June 14th, 2013

Announcements

An Innovative material for the Green Earth: Simple and inexpensive process to make a material for CO2 adsorption June 17th, 2013

Polymer-coated catalyst protects "artificial leaf" June 17th, 2013

Efficient and inexpensive: Researchers develop catalyst material for fuel cells: Platinum-nickel nano-octahedra save 90 percent platinum June 17th, 2013

AXEON Acquires Assets of Leading Reverse Osmosis Systems Manufacturer June 17th, 2013